Gpr75 Deletion in Adipocytes Protects From Diet‐Induced Obesity: Changes in Glucose Homeostasis and Inflammatory Responses
The FASEB Journal · 2026
DOI: 10.1096/fj.202504597r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Sakib Hossain und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, New York Medical College, Valhalla, New York, USA. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Obesity, Adipocytes, Homeostasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health (NIH).
Abstract (Originalsprache)
Loss of function G‐protein coupled receptor 75 (GPR75 ) variants in humans are associated with leanness, and Gpr75 null mice are protected from diet‐induced obesity (DIO). However, the mechanisms underlying this protection are largely unknown. Here, we investigated the contribution of adipocyte‐derived Gpr75 to DIO. Adipocyte‐specific Gpr75 knockout (adipo‐ Gpr75 −/− ) male and female mice and their wild‐type (WT) littermates were placed on a high‐fat diet (HFD) for 14 weeks. Metabolic parameters including body weight, energy intake and expenditure, activity, and glucose metabolism were monitored before and after diet feeding. While WT mice obtained a diabetogenic phenotype on HFD, the adipo‐ Gpr75 −/− counterparts were protected. This protection showed sexual dimorphism. Female adipo‐ Gpr75 −/− mice displayed a 50% ( p < 0.001) decrease in weight gain and adiposity compared to WT, whereas male adipo‐ Gpr75 −/− gained weight like WT mice. Interestingly, both male and female adipo‐ Gpr75 −/− mice exhibited improved glucose handling compared to WT, which was correlated to decreased adiposity, abrogated adipose tissue inflammation, and increased insulin sensitivity in skeletal muscle. Importantly, no differences in food intake were observed; however, adipo‐ Gpr75 −/− mice exhibited increased activity and energy expenditure, regardless of sex. Taken together, these findings demonstrate that deletion of GPR75 specifically in adipocytes is sufficient to confer protection against DIO and suggest that adipocyte‐derived GPR75 contributes importantly to the pathogenesis of DIO potentially by mechanisms that may include promotion of inflammation, impairment of insulin signaling, and disruption of metabolic homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Medicine, New York Medical College, Valhalla, New York, USA.
- National Institute of Environmental Health Sciences, National Institutes of Health, North Carolina, USA.
ORCID-Profile: Michal Laniado Schwartzman
Förderung
- National Institutes of Health (NIH)
Zitieren
APA
Hossain, S., Villegas, E., Liapes, C., Sultana, N., Krasniqi, D., Diegisser, D., Castro, A., Williams, C., Gruzdev, A., Zeldin, D. C., Garcia, V., & Schwartzman, M. L. (2026). Gpr75 Deletion in Adipocytes Protects From Diet‐Induced Obesity: Changes in Glucose Homeostasis and Inflammatory Responses. The FASEB Journal. https://doi.org/10.1096/fj.202504597r
Vancouver
Hossain S, Villegas E, Liapes C, Sultana N, Krasniqi D, Diegisser D, et al. Gpr75 Deletion in Adipocytes Protects From Diet‐Induced Obesity: Changes in Glucose Homeostasis and Inflammatory Responses. The FASEB Journal. 2026. doi:10.1096/fj.202504597r
BibTeX
@article{Hossain2026,
author = {Hossain, Sakib and Villegas, Elizabeth and Liapes, Catherine and Sultana, Nahid and Krasniqi, Dorina and Diegisser, Danielle and Castro, Ana and Williams, Comfort and Gruzdev, Artiom and Zeldin, Darryl C and Garcia, Victor and Schwartzman, Michal Laniado},
title = {Gpr75 Deletion in Adipocytes Protects From Diet‐Induced Obesity: Changes in Glucose Homeostasis and Inflammatory Responses},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202504597r}
}
EUVIMED